Drug discovery and development in its entirety, encompassing genomics and proteomics research, applications, technologies, and tactics to speed up the pace and productivity of drug development. Pharmacotherapy, Clinical trials, Case studies in a variety of therapeutic and disease domains, translational medicine, translational and preclinical models

Pharmacokinetics studies the body's absorption, distribution, metabolization, and excretion of a substance.

A drug's organ-specific mechanism of action and its biochemical and physiological effects, including effects at the cellular level, are studied by the discipline of pharmacodynamics.

Pharmacokinetics is “what the body does to the drug," whereas pharmacodynamics is “what the drug does to the body.

Gene testing for drugs, Personalized medicine and pharmacogenomics Challenges, Current restrictions on drug labelling Drug Sensitivity and Genetics, Costs and coverage of pharmacogenomics testing Predicting drug-drug interactions is a difficult task. Polypharmacy, Methods based on associations and expressions, Pathway-based techniques and cheminformatics Incorporation of pharmacogenomics into clinical practise Phenotyping and genotyping are two terms that are used interchangeably.

Four main themes are the focus of the Division of Pharmaceutics and Pharmacology: (1) cancer therapeutics, (2) cell protective therapies, (3) drug delivery methods, and (4) drug toxicity.

(1) Cancer Therapeutics: the detection of drug resistance mechanisms, the discovery of anti-cancer drug targets, and the optimization of drug delivery to enhance outcomes for cancer patients.

(2) Cell Protective Therapies: The creation of therapies to lessen inflammatory and degenerative processes will be aided by preclinical research on the mechanisms of cell death and cell survival.

(3) Drug Delivery Systems: Future medications to treat human diseases will be developed using pharmaceutical chemistry, biotechnology, and RNA nanotechnology.

(4) Drug Toxicity: Understanding how drugs enter healthy cells and have toxic effects will assist with the development of patient-health improvement strategies.

Pharmaceutical microbiology and animal biotechnology have evolved as a useful field for the productions of biologics from microbial cells or animal or human cell lines. Biotechnological concepts and manipulations in the these filed has enhanced the production, variety and types of biologics produced. These field are expected to grow further in the future.

Pharmaceutical and medical chemistry are interdisciplinary scientific topics that deal with drug development, molecular mechanisms of pathogenesis, pharmaceutics, pharmacology, toxicology, organic chemistry, and more. Individual investigations in both disciplines provide improved insights and understanding for the creation of novel medications and therapies.

Pharmaceutical nanotechnology provides innovative tools and technology, as well as opportunities and scope, in many areas of the healthcare industry, and it is now well-established as a specialised area for drug delivery, diagnostics, prognostics, and various treatment procedures, thanks to its nano-engineered tools and techniques. By overcoming the constraints of present technology in the pharmaceutical sector, it will have a significant impact in the future.

 Nanotechnology, polymer science, and biomaterial sciences all have a lot of potential and opportunity for developing innovative medication delivery techniques and systems.

Recent therapeutic application and formulation system development efforts to boost medication delivery potential, Drug Delivery Carrier, Nanoparticles, Mucoadhesive Drug Delivery System, Novel Drug Delivery System and Market Opportunities, Drug Delivery Biomaterials, Routes of Administration, Future Opportunities and Challenges, Drug Therapy

The most often utilized drug delivery systems are the oral and parenteral drug administration systems. Alternative drug delivery mechanisms such as pulmonary drug delivery, transdermal drug delivery, prodrug delivery, ocular drug delivery, and transmucosal drug delivery will be discussed in this session.

The obstacles of delivering protein-based treatments have grown dramatically since the development of peptide and protein medicines. This session will cover issues in various types and routes of peptide and protein drug delivery, vaccine design and drug delivery, recent advances in protein-based drug delivery, and solutions to overcome drug delivery-related constraints.

In the field of drug regulation, pharmacovigilance is a term that is used to describe the monitoring of Trials in Medicine, Clinical safety prior to marketing, Safety of drugs once they've been released, Strategies for risk management, Data mining and signal detection Drug interaction detection, Harmonization of drug regulatory requirements on a global scale, Management of risks and crises Traditional and Herbal Medicines, Vaccines and biological medicines are two examples of vaccines.